Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICU) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to 1955.74%.

  • SeaStar Medical Holding's EBITDA Margin rose 45972000.0% to 1955.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 1580.48%, marking a year-over-year increase of 219665800.0%. This contributed to the annual value of 13216.3% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's EBITDA Margin is 1955.74%, which was up 45972000.0% from 519.53% recorded in Q2 2025.
  • Over the past 5 years, SeaStar Medical Holding's EBITDA Margin peaked at 1666.67% during Q2 2023, and registered a low of 7114.93% during Q4 2024.
  • For the 3-year period, SeaStar Medical Holding's EBITDA Margin averaged around 2103.28%, with its median value being 1304.44% (2025).
  • Data for SeaStar Medical Holding's EBITDA Margin shows a peak YoY increase of 45972000bps (in 2025) and a maximum YoY decrease of 45972000bps (in 2025) over the last 5 years.
  • SeaStar Medical Holding's EBITDA Margin (Quarter) stood at 1666.67% in 2023, then tumbled by -527bps to 7114.93% in 2024, then skyrocketed by 73bps to 1955.74% in 2025.
  • Its EBITDA Margin stands at 1955.74% for Q3 2025, versus 519.53% for Q2 2025 and 1304.44% for Q1 2025.